Sign in

NCT05953272Completed

A Clinical Trial to Study the Effects of Bobath Therapy With and Without EMG Biofeedback Therapy in Stroke Patients

Comparative Efficacy of EMG Biofeedback Therapy Along With Bobath Therapy and Bobath Therapy Alone on Lower Extremity Functions, Balance and Gait in Patients With Stroke: a Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 22 May 2025

Brief summary (registry, in English)

Stroke is a leading cause of disability worldwide. It has a negative impact on the cognitive and sensorimotor functions. Motor recovery becomes essential in rehabilitation phase to make the patient independent in activities of daily living along with improved lower extremity function, balance and gait. Studies show that both EMG Biofeedback therapy and Bobath therapy is effective in improving lower extremity function. Out of those studies, to the best of the investigators knowledge, no study has been conducted to find out the efficacy of EMG Biofeedback therapy along with Bobath therapy on lower extremity functions, balance and gait in stroke patients. Therefore the purpose of the study is to find out the comparative efficacy of EMG Biofeedback therapy along with Bobath therapy and Bobath therapy alone on lower extremity functions, balance and gait in patients with stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
1 Jul 2023
Start date
1 May 2023
Primary completion date
30 Apr 2024
Lead sponsor
National Institute for Locomotor Disabilities (Divyangjan), India
Diseases
Stroke
NCT number
NCT05953272

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 1 May 2023 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Musculoskeletal conditions like - fracture, contracture and deformity in lower extremity.
  • Diagnosed neurological diseases like - Parkinsonism, Dementia, Peripheral nerve injury in the lower extremity etc.
  • Diagnosed systemic diseases like - uncontrolled hypertension etc. and/or peripheral vascular disease in lower extremity like - Raynaud's disease etc.

Other

  • Patient with any sensory deficit of the lower extremity.
  • Problems with vision, like - homonymous hemianopsia, hemiagnosia, visual agnosia etc.
  • Patients with hearing loss.
  • Patients with hemineglect.
  • Patients with sensory, conduction or global aphasia.

Who the study is looking for

  • Both male and female patients aged between 40 - 65 years.
  • Patients with first attack of stroke, diagnosed by a physician.
  • Duration of stroke 3 months to 3 years.
  • Patient has no cognitive impairment and has a MMSE Score ≥ 24.
  • Grade of spasticity upto 2 in lower extremity on Modified Ashworth Scale.
  • Patient is in Brunnstrom lower limb recovery stage 3 and 4.
  • Patient should have passive 10° or greater ankle dorsiflexion.
  • Patient can sit independently on a plinth.
  • Patient should be ambulatory either independently or with some assistive aid.

Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
National Institute for Locomotor Disabilities (Divyangjan)
Coordinator of this site? Confirm its status
KolkataIndiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.